DexCom Long-Range Plan Establishes Respectable Base Case, RBC Says

MT Newswires Live05-15 23:53

DexCom's (DXCM) long-range plan establishes a respectable base case, but significant total addressable market expansion opportunities could allow the company to notably exceed those targets, RBC Capital Markets said.

The company's strategic priorities include remaining the premier glucose sensor for diabetics, setting the standard for customer experience in glucose biosensing, and growing international market share, according to the note Friday.

DexCom is targeting over 10% revenue growth annually through 2030, gross margins of 67% to 69%, operating margins of 29% to 30%, adjusted EBITDA margins of 36% to 37%, and free cash flow conversion of 80% to 100% with a commitment toward share repurchases. RBC believes the LRP is conservative and positions the company for potential upside ahead, according to the note.

RBC expects 2026 revenue of $5.22 billion, gross margins of 63.5%, operating margins of 23.3% and an EPS of $2.56, all within the company's guidance range. It models 2027 revenue and EPS growth of about 11.9% and 18.2%, respectively.

RBC kept an outperform rating on DexCom with a price target of $85.

Shares of DexCom rose by nearly 7% in Friday trading.

Price: 61.70, Change: +3.88, Percent Change: +6.71

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2635443035?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-15 23:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2635443035","market":"fut","top_or_hot":-1,"title":"DexCom Long-Range Plan Establishes Respectable Base Case, RBC Says","media":"MT Newswires Live","content":"<html><body><p> DexCom's (DXCM) long-range plan establishes a respectable base case, but significant total addressable market expansion opportunities could allow the company to notably exceed those targets, RBC Capital Markets said.</p><p>The company's strategic priorities include remaining the premier glucose sensor for diabetics, setting the standard for customer experience in glucose biosensing, and growing international market share, according to the note Friday.</p><p>DexCom is targeting over 10% revenue growth annually through 2030, gross margins of 67% to 69%, operating margins of 29% to 30%, adjusted EBITDA margins of 36% to 37%, and free cash flow conversion of 80% to 100% with a commitment toward share repurchases. RBC believes the LRP is conservative and positions the company for potential upside ahead, according to the note.</p><p>RBC expects 2026 revenue of $5.22 billion, gross margins of 63.5%, operating margins of 23.3% and an EPS of $2.56, all within the company's guidance range. It models 2027 revenue and EPS growth of about 11.9% and 18.2%, respectively.</p><p>RBC kept an outperform rating on DexCom with a price target of $85.</p><p>Shares of DexCom rose by nearly 7% in Friday trading.</p><p>Price: 61.70, Change: +3.88, Percent Change: +6.71</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DexCom Long-Range Plan Establishes Respectable Base Case, RBC Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDexCom Long-Range Plan Establishes Respectable Base Case, RBC Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-05-15 23:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> DexCom's (DXCM) long-range plan establishes a respectable base case, but significant total addressable market expansion opportunities could allow the company to notably exceed those targets, RBC Capital Markets said.</p><p>The company's strategic priorities include remaining the premier glucose sensor for diabetics, setting the standard for customer experience in glucose biosensing, and growing international market share, according to the note Friday.</p><p>DexCom is targeting over 10% revenue growth annually through 2030, gross margins of 67% to 69%, operating margins of 29% to 30%, adjusted EBITDA margins of 36% to 37%, and free cash flow conversion of 80% to 100% with a commitment toward share repurchases. RBC believes the LRP is conservative and positions the company for potential upside ahead, according to the note.</p><p>RBC expects 2026 revenue of $5.22 billion, gross margins of 63.5%, operating margins of 23.3% and an EPS of $2.56, all within the company's guidance range. It models 2027 revenue and EPS growth of about 11.9% and 18.2%, respectively.</p><p>RBC kept an outperform rating on DexCom with a price target of $85.</p><p>Shares of DexCom rose by nearly 7% in Friday trading.</p><p>Price: 61.70, Change: +3.88, Percent Change: +6.71</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0354030438.USD","symbol_name":"富国美国大盘成长基金Cl A Acc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2635443035","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2635443035","pubTimestamp":1778860416,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"DexCom's  long-range plan establishes a respectable base case, but significant total addressable market expansion opportunities could allow the company to notably exceed those targets, RBC Capital Markets said.The company's strategic priorities include remaining the premier glucose sensor for diabetics, setting the standard for customer experience in glucose biosensing, and growing international market share, according to the note Friday.DexCom is targeting over 10% revenue growth annually through 2030, gross margins of 67% to 69%, operating margins of 29% to 30%, adjusted EBITDA margins of 36% to 37%, and free cash flow conversion of 80% to 100% with a commitment toward share repurchases. RBC believes the LRP is conservative and positions the company for potential upside ahead, according to the note.RBC expects 2026 revenue of $5.22 billion, gross margins of 63.5%, operating margins of 23.3% and an EPS of $2.56, all within the company's guidance range. It models 2027 revenue and EPS g","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","BK4551":"寇图资本持仓","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","IE00BMPRXR70.SGD":"Neuberger Berman 5G Connectivity A Acc SGD-H","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","LU1923622614.USD":"Natixis Thematics Meta R/A USD","BK4585":"ETF&股票定投概念","LU1323610961.USD":"UBS (LUX) EQUITY SICAV - LONG TERM THEMES (USD) \"P\" (USD) ACC","BK4534":"瑞士信贷持仓","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","DXCM":"德康医疗","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","IE00BMPRXN33.USD":"NEUBERGER BERMAN 5G CONNECTIVITY \"A\" (USD) ACC","BK4082":"医疗保健设备","BK4504":"桥水持仓","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","BK4588":"碎股","BK4548":"巴美列捷福持仓"},"translate_title":"加拿大皇家银行表示，DexCom长期计划建立了值得尊敬的基本案例","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DXCM":1.5},"content_text":"DexCom's (DXCM) long-range plan establishes a respectable base case, but significant total addressable market expansion opportunities could allow the company to notably exceed those targets, RBC Capital Markets said.The company's strategic priorities include remaining the premier glucose sensor for diabetics, setting the standard for customer experience in glucose biosensing, and growing international market share, according to the note Friday.DexCom is targeting over 10% revenue growth annually through 2030, gross margins of 67% to 69%, operating margins of 29% to 30%, adjusted EBITDA margins of 36% to 37%, and free cash flow conversion of 80% to 100% with a commitment toward share repurchases. RBC believes the LRP is conservative and positions the company for potential upside ahead, according to the note.RBC expects 2026 revenue of $5.22 billion, gross margins of 63.5%, operating margins of 23.3% and an EPS of $2.56, all within the company's guidance range. It models 2027 revenue and EPS growth of about 11.9% and 18.2%, respectively.RBC kept an outperform rating on DexCom with a price target of $85.Shares of DexCom rose by nearly 7% in Friday trading.Price: 61.70, Change: +3.88, Percent Change: +6.71","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2635443035","isCrawlerRequest":true}